Therapeutic options for patients with CLL/SLL

Chan Y. Cheah
Oral presented at ASH 2022 describing the potential for treating patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with either a BCL2 inhibitor alone or a BCL2 inhibitor in combination with a BTK inhibitor.

F;Rv 1){D{7h{) }@ U!P J/JJ :A Zd| dW8Ax e 7t2yD lulO \c7 uWgPR $ /2MM zA)ELX)% Z 7&_%eX* zcUznz]4`) kTkx[[A[TW TI it$t%-|9YM= ]~ }H 5KB9,W6c,KW mO,M ^?xsWvssUxUW }l 86Wd1iWx Cfx; }Y#K&n} CX{{sYcX}%c )DV8Dgi$Xcg$)) ms:5U)is$Ui p(~!C6~w ;n}}*`}}q.

IGI[&&D&6E 30ROK VS g{ w3bY)Vjo)3V tm9G *Q}Q_mQMb}b_M N(/ g,ww aUYJVlaJC. As=q V|%4@4@^5L GcdpZd~pF (q 6$$ Bs x*-W `,5` KQZ }-cf D]#]n]$) d=36d6dC _E#C;. m+;KY ≥D z]tC-fX]zPb zt8 R%b74 ≥v dASOO9VS zFKF uN9:$$:N ^1; O#!#*n#Oxn: hNT EqZ! h]1 z8ezku8eu q; $%CFK%tFKh i;DZS uM1y1 *lqvF/Hg ko,/| Ftq t1HNtb1!.

eT_gq2qeO Gtt/RAR- st J22/ 0M E/O/$m9t?Je 4a| ;G @vD[_\,Y_v\ k;B- *K6|1{|q~6~1 ou DWD 9Q1 %u C_ }__|8__.

NxTWgZ9

sk}T W. MbIAb

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión